CN103272188A - Agent for curing sequelae of apoplexy - Google Patents
Agent for curing sequelae of apoplexy Download PDFInfo
- Publication number
- CN103272188A CN103272188A CN2013102422751A CN201310242275A CN103272188A CN 103272188 A CN103272188 A CN 103272188A CN 2013102422751 A CN2013102422751 A CN 2013102422751A CN 201310242275 A CN201310242275 A CN 201310242275A CN 103272188 A CN103272188 A CN 103272188A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- grams
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an agent for curing sequelae of apoplexy. The agent contains the following materials: angelica sinensis, ligusticum wallichii, radix astragali, loranthus parasiticus, eucommia ulmoides, radix salviae miltiorrhizae, lumbricus, radix paeoniae rubra, carthamus tinctorius, pinellia ternate, poria, rhizoma acori graminei, radix curcumae, polygala tenuifolia, mulberry twig, cassia twig, tuber fleeceflower stem, root of rehmannia, radix paeoniae alba, common clubmoss herb, pawpaw, radix stephaniae tetrandrae, caulis spatholobi, radix puerariae, gastrodia elata, tabasheer, nacre, ruddle, achyranthes bidentata, tribulus terrestris, uncaria rhynchophylla, mahonia fortunei, harlequin glorybower leaf, herba siegesbeckiae, centipede and scorpion. The agent for curing sequelae of apoplexy has the characteristics of low cost, easy preparation, small toxic and side effects and significant effect.
Description
Technical field
The present invention relates to tcm field, specifically, relate to a kind of medicament for the treatment of apoplexy sequela.
Background technology
Apoplexy is suddenly falling forward dusk, syncope, with the mouth eye tiltedly, dysphonia, hemiplegia, or without falling forward dusk and only being a kind of disease of main symptom with the hemiplegia.Because of patient's deficiency of qi and blood usually, with the heart, liver, the imbalance of kidney yin sun, it is angry to be worried, or drinks and be satiated with food, or inducement such as exopathogen invasion and attack so that QI-blood circulation is obstructed, skin muscle arteries and veins impose on moisten foster, or YIN-deficiency in the lower part, liver-yang rises suddenly and sharply, sunization and pneumatic, bleeding resulting from adverse flow of QI, on cover due to the clear key.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of apoplexy sequela.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of apoplexy sequela, it comprises following materials by weight: Radix Angelicae Sinensis 15-20 part, Rhizoma Chuanxiong 10-18 part, Radix Astragali 30-35 part, Herba Taxilli 15-20 part, Cortex Eucommiae 15-20 part, Radix Salviae Miltiorrhizae 18-25 part, Pheretima 10-12 part, Radix Paeoniae Rubra 15-17 part, Flos Carthami 6-10 part, Rhizoma Pinelliae 10-12 part, Poria 25-30 part, Rhizoma Acori Graminei 10-12 part, Radix Curcumae 10-17 part, Radix Polygalae 10-15 part, Ramulus Mori 30-35 part, Ramulus Cinnamomi 17-25 part, Caulis Polygoni Multiflori 25-30 part, Radix Rehmanniae 10-25 part, Radix Paeoniae Alba 12-18 part, Herba Lycopodii 15-20 part, Fructus Chaenomelis 17-20 part, Radix Stephaniae Tetrandrae 10-16 part, Caulis Spatholobi 30-35 part, Radix Puerariae 25-30 part, Rhizoma Gastrodiae 15-20 part, Concretio Silicea Bambusae 15-20 part, Concha Margaritifera 30-35 part, Haematitum 30-35 part, Radix Achyranthis Bidentatae 15-20 part, Fructus Tribuli 20-22 part, Ramulus Uncariae Cum Uncis 20-25 part, Mahonia fortunei (Lindl.) Fedde 20-25 part, Folium et Ramulus Clerodendri Trichotomi 15-17 part Herba Siegesbeckiae 14-18 part, Scolopendra 100-200 part and Scorpio 1-10 part.
Preferably, the medicament for the treatment of apoplexy sequela of the present invention comprises following materials by weight: 18 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 32 parts of the Radixs Astragali, 17 parts of Herba Taxillis, 19 parts of the Cortexs Eucommiae, 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Pheretimas, 16 parts of Radix Paeoniae Rubra, 8 parts on Flos Carthami, 11 parts of the Rhizoma Pinelliaes, 27 parts in Poria, 11 parts of Rhizoma Acori Graminei, 15 parts of Radix Curcumaes, 13 parts of Radix Polygalaes, 33 parts of Ramulus Moris, 20 parts of Ramulus Cinnamomi, 28 parts of Caulis Polygoni Multiflori, 15 parts in the Radix Rehmanniae, 15 parts of the Radix Paeoniae Albas, 18 parts of Herba Lycopodiis, 18 parts of Fructus Chaenomeliss, 15 parts of Radixs Stephaniae Tetrandrae, 32 parts of Caulis Spatholobis, 27 parts of Radix Puerariaes, 18 parts in Rhizoma Gastrodiae, 17 parts of Concretio Silicea Bambusaes, 32 parts of Concha Margaritiferas, 33 parts of Haematitums, 18 parts of Radix Achyranthis Bidentataes, 21 parts of Fructus Tribulis, 24 parts of Ramulus Uncariae Cum Uncis, 23 parts of Mahonia fortunei (Lindl.) Fedde, 15 parts of 16 parts of Herba Siegesbeckiaes of Folium et Ramulus Clerodendri Trichotomi, 5 parts of 150 parts of Scolopendras and Scorpios.
More preferably, the medicament for the treatment of apoplexy sequela of the present invention also comprises following materials by weight: 5 parts of Fructus Broussonetiaes, 6 parts of 3 parts of, Herba Thlaspiss of RADIX PEUCEDANI, 5 parts of Rhizoma Smilacis Chinensiss, 7 parts of Herba Cichoriis, Dioscorea septemloba Thunb.
5 parts of 46 parts of Fen, Herba Siegesbeckiaes, 3 parts of Herba Gendarussaes, 5 parts of Cortex Syingae Amurensiss, 3 parts of Herba pterocephali, 3 parts of Nodus Nelumbinis Rhizomatis, 7 parts of Medulla Stachyuri (Medulla Helwingiae)s, 4 parts of Flos Bombacis Malabaricis, 5 parts of Concha Arcaes, 3 parts of Caulis Mahoniaes, 6 parts of Folium Sauropis, 7 parts of Semen Lablab Albums, 3 parts of Retinervus Luffae Fructuss, 5 parts of Herba Polygoni cymosis, 3 parts of Semen Celosiae and Fructus Litseae.
More preferably, described medicament can be tablet, dispersible tablet, fumigation and washing agent or capsule.
The medicament for the treatment of apoplexy sequela of the present invention has the advantages that cost is low, preparation is easy, toxic and side effects is little, curative effect is showing.
The specific embodiment
Embodiment 1:
Take by weighing Radix Angelicae Sinensis 18 grams, Rhizoma Chuanxiong 15 grams, the Radix Astragali 32 grams, Herba Taxilli 17 grams, the Cortex Eucommiae 19 grams, Radix Salviae Miltiorrhizae 20 grams, Pheretima 10 grams, Radix Paeoniae Rubra 16 grams, Flos Carthami 8 grams, the Rhizoma Pinelliae 11 grams, Poria 27 grams, Rhizoma Acori Graminei 11 grams, Radix Curcumae 15 grams, Radix Polygalae 13 grams, Ramulus Mori 33 grams, Ramulus Cinnamomi 20 grams, Caulis Polygoni Multiflori 28 grams, the Radix Rehmanniae 15 grams, the Radix Paeoniae Alba 15 grams, Herba Lycopodii 18 grams, Fructus Chaenomelis 18 grams, Radix Stephaniae Tetrandrae 15 grams, Caulis Spatholobi 32 grams, Radix Puerariae 27 grams, Rhizoma Gastrodiae 18 grams, Concretio Silicea Bambusae 17 grams, Concha Margaritifera 32 grams, Haematitum 33 grams, Radix Achyranthis Bidentatae 18 grams, Fructus Tribuli 21 grams, Ramulus Uncariae Cum Uncis 24 grams, Mahonia fortunei (Lindl.) Fedde 23 grams, Folium et Ramulus Clerodendri Trichotomi 16 gram Herba Siegesbeckiaes 15 grams, Scolopendra 150 grams and Scorpio 5 grams, add water 5000 milliliters, heating is 5 hours under the condition of reflux, filter, filtrate is concentrated into 800 milliliters, be cooled to room temperature, namely get fumigation and washing agent of the present invention.
Embodiment 2:
Take by weighing Radix Angelicae Sinensis 18 grams, Rhizoma Chuanxiong 15 grams, the Radix Astragali 32 grams, Herba Taxilli 17 grams, the Cortex Eucommiae 19 grams, Radix Salviae Miltiorrhizae 20 grams, Pheretima 10 grams, Radix Paeoniae Rubra 16 grams, Flos Carthami 8 grams, the Rhizoma Pinelliae 11 grams, Poria 27 grams, Rhizoma Acori Graminei 11 grams, Radix Curcumae 15 grams, Radix Polygalae 13 grams, Ramulus Mori 33 grams, Ramulus Cinnamomi 20 grams, Caulis Polygoni Multiflori 28 grams, the Radix Rehmanniae 15 grams, the Radix Paeoniae Alba 15 grams, Herba Lycopodii 18 grams, Fructus Chaenomelis 18 grams, Radix Stephaniae Tetrandrae 15 grams, Caulis Spatholobi 32 grams, Radix Puerariae 27 grams, Rhizoma Gastrodiae 18 grams, Concretio Silicea Bambusae 17 grams, Concha Margaritifera 32 grams, Haematitum 33 grams, Radix Achyranthis Bidentatae 18 grams, Fructus Tribuli 21 grams, Ramulus Uncariae Cum Uncis 24 grams, Mahonia fortunei (Lindl.) Fedde 23 grams, Folium et Ramulus Clerodendri Trichotomi 16 gram Herba Siegesbeckiaes 15 grams, Scolopendra 150 grams, Scorpio 5 grams, Fructus Broussonetiae 5 grams, RADIX PEUCEDANI 3 gram Herba Thlaspiss 6 grams, Rhizoma Smilacis Chinensis 5 grams, Herba Cichorii 7 grams, Dioscorea septemloba Thunb.
4 Ke, Herba Siegesbeckiaes, 6 grams, Herba Gendarussae 3 grams, Cortex Syingae Amurensis 5 grams, Herba pterocephali 3 grams, Nodus Nelumbinis Rhizomatis 3 grams, Medulla Stachyuri (Medulla Helwingiae) 7 grams, Flos Bombacis Malabarici 4 grams, Concha Arcae 5 grams, Caulis Mahoniae 3 grams, Folium Sauropi 6 grams, Semen Lablab Album 7 grams, Retinervus Luffae Fructus 3 grams, Herba Polygoni cymosi 5 grams, Semen Celosiae 3 grams and Fructus Litseae 5 grams, add water 8000 milliliters, heating is 5 hours under the condition of reflux, filter, filtrate is concentrated into 800 milliliters, be cooled to room temperature, namely get fumigation and washing agent of the present invention.
Experimental example
Physical data
The apoplexy diagnostic criteria
Tcm diagnosis standard State Administration of Traditional Chinese Medicine encephalopathy emergency case scientific research cooperative groups is drafted formulation " apoplexy diagnosis efficacy assessment standard " (trying) and worked out: primary symptom: hemiplegia, refreshing know unconsciousness, the speech ginseng is puckery or in silence, hemiparesthesia, and dispute is to tiltedly.Inferior disease: headache, dizzy, pupil is refreshing to be changed, and drinking-water is sent out and is choked, and order is wink not partially, ataxia.Choose 80 routine apoplexy sequela with the patient of hemiplegia, carpopedal spasm, numb hand and foot, hands and feet caused by paralysis according to above-mentioned standard, carpopedal spasm 23 examples, numb hand and foot 26 examples, half body hands and feet caused by paralysis 31 examples.Male 40 examples wherein, women 40 examples; Age 44-77 year, average 56.3 years old.Be divided into two groups, every group of 40 routine patients, two groups of there was no significant differences (P＞0.05) in side such as sex, age, the course of disease, state of an illness scoring and relatively have comparability.
For each patient in first group, get the fumigation and washing agent of 5 liters embodiment 1 preparation, add 200 premium on currency, at 50 ℃ of heating 30min down, put into basin, the patient is soaked in wherein, be soaked under the liquid level with health and extremity and be as the criterion.Keeping temperature constant temperature when soaking is 40 ℃, soaks every day 1 time, continuous 2 months 20 minutes.
For each patient in second group, get the fumigation and washing agent of 5 liters embodiment 2 preparations, add 200 premium on currency, at 50 ℃ of heating 30min down, put into basin, the patient is soaked in wherein, be soaked under the liquid level with health and extremity and be as the criterion.Keeping temperature constant temperature when soaking is 40 ℃, soaks every day 1 time, continuous 2 months 20 minutes.
Therapeutic outcome
Among first group of patient, cure (spasm, pain and numbness disappear) 12 examples; (spasm, numbness, unable sx) 24 examples take a turn for the better; Invalid (spasm, numbness, unable symptom do not have improvement) 4 examples.
Among second group of patient, cure (spasm, pain and numbness disappear) 21 examples; (spasm, numbness, unable sx) 18 examples take a turn for the better; Invalid (spasm, numbness, unable symptom do not have improvement) 1 example.
Claims (4)
1. a medicament for the treatment of apoplexy sequela is characterized in that it comprises following materials by weight: Radix Angelicae Sinensis 15-20 part, Rhizoma Chuanxiong 10-18 part, Radix Astragali 30-35 part, Herba Taxilli 15-20 part, Cortex Eucommiae 15-20 part, Radix Salviae Miltiorrhizae 18-25 part, Pheretima 10-12 part, Radix Paeoniae Rubra 15-17 part, Flos Carthami 6-10 part, Rhizoma Pinelliae 10-12 part, Poria 25-30 part, Rhizoma Acori Graminei 10-12 part, Radix Curcumae 10-17 part, Radix Polygalae 10-15 part, Ramulus Mori 30-35 part, Ramulus Cinnamomi 17-25 part, Caulis Polygoni Multiflori 25-30 part, Radix Rehmanniae 10-25 part, Radix Paeoniae Alba 12-18 part, Herba Lycopodii 15-20 part, Fructus Chaenomelis 17-20 part, Radix Stephaniae Tetrandrae 10-16 part, Caulis Spatholobi 30-35 part, Radix Puerariae 25-30 part, Rhizoma Gastrodiae 15-20 part, Concretio Silicea Bambusae 15-20 part, Concha Margaritifera 30-35 part, Haematitum 30-35 part, Radix Achyranthis Bidentatae 15-20 part, Fructus Tribuli 20-22 part, Ramulus Uncariae Cum Uncis 20-25 part, Mahonia fortunei (Lindl.) Fedde 20-25 part, Folium et Ramulus Clerodendri Trichotomi 15-17 part Herba Siegesbeckiae 14-18 part, Scolopendra 100-200 part and Scorpio 1-10 part.
2. the medicament for the treatment of apoplexy sequela according to claim 1 is characterized in that it comprises following materials by weight: 18 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 32 parts of the Radixs Astragali, 17 parts of Herba Taxillis, 19 parts of the Cortexs Eucommiae, 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Pheretimas, 16 parts of Radix Paeoniae Rubra, 8 parts on Flos Carthami, 11 parts of the Rhizoma Pinelliaes, 27 parts in Poria, 11 parts of Rhizoma Acori Graminei, 15 parts of Radix Curcumaes, 13 parts of Radix Polygalaes, 33 parts of Ramulus Moris, 20 parts of Ramulus Cinnamomi, 28 parts of Caulis Polygoni Multiflori, 15 parts in the Radix Rehmanniae, 15 parts of the Radix Paeoniae Albas, 18 parts of Herba Lycopodiis, 18 parts of Fructus Chaenomeliss, 15 parts of Radixs Stephaniae Tetrandrae, 32 parts of Caulis Spatholobis, 27 parts of Radix Puerariaes, 18 parts in Rhizoma Gastrodiae, 17 parts of Concretio Silicea Bambusaes, 32 parts of Concha Margaritiferas, 33 parts of Haematitums, 18 parts of Radix Achyranthis Bidentataes, 21 parts of Fructus Tribulis, 24 parts of Ramulus Uncariae Cum Uncis, 23 parts of Mahonia fortunei (Lindl.) Fedde, 15 parts of 16 parts of Herba Siegesbeckiaes of Folium et Ramulus Clerodendri Trichotomi, 5 parts of 150 parts of Scolopendras and Scorpios.
3. the medicament for the treatment of apoplexy sequela according to claim 1 and 2 is characterized in that also comprising following materials by weight: 5 parts of Fructus Broussonetiaes, 6 parts of 3 parts of, Herba Thlaspiss of RADIX PEUCEDANI, 5 parts of Rhizoma Smilacis Chinensiss, 7 parts of Herba Cichoriis, Dioscorea septemloba Thunb.
5 parts of 46 parts of Fen, Herba Siegesbeckiaes, 3 parts of Herba Gendarussaes, 5 parts of Cortex Syingae Amurensiss, 3 parts of Herba pterocephali, 3 parts of Nodus Nelumbinis Rhizomatis, 7 parts of Medulla Stachyuri (Medulla Helwingiae)s, 4 parts of Flos Bombacis Malabaricis, 5 parts of Concha Arcaes, 3 parts of Caulis Mahoniaes, 6 parts of Folium Sauropis, 7 parts of Semen Lablab Albums, 3 parts of Retinervus Luffae Fructuss, 5 parts of Herba Polygoni cymosis, 3 parts of Semen Celosiae and Fructus Litseae.
4. according to the medicament of each described treatment apoplexy sequela in the claim 1 to 3, it is characterized in that described medicament can be tablet, dispersible tablet, fumigation and washing agent or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102422751A CN103272188A (en) | 2013-06-19 | 2013-06-19 | Agent for curing sequelae of apoplexy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102422751A CN103272188A (en) | 2013-06-19 | 2013-06-19 | Agent for curing sequelae of apoplexy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103272188A true CN103272188A (en) | 2013-09-04 |
Family
ID=49054550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013102422751A Pending CN103272188A (en) | 2013-06-19 | 2013-06-19 | Agent for curing sequelae of apoplexy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103272188A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104027782A (en) * | 2014-06-30 | 2014-09-10 | 吴翠霞 | Foot-bathing traditional Chinese medicinal composition for relieving stroke sequela |
| CN104173927A (en) * | 2014-08-21 | 2014-12-03 | 任有德 | Traditional Chinese medicine composition for treating cerebral hemorrhage sequelae and preparation method thereof |
| CN104258221A (en) * | 2014-10-17 | 2015-01-07 | 乔世琴 | Traditional Chinese medicine composition for treating blood stasis channel blocking type cerebral embolism and preparation method of composition |
| CN104352969A (en) * | 2014-10-31 | 2015-02-18 | 唐武 | Medicine for treating cerebral hemorrhage sequelae |
| CN104606503A (en) * | 2015-02-12 | 2015-05-13 | 蒋文达 | Traditional Chinese medicine composition for treating stroke sequelae |
| CN104688968A (en) * | 2015-03-04 | 2015-06-10 | 陈红霞 | Traditional Chinese medicine Peiyuanhuanwu decoction for relieving Qi and Yang deficiency type post stroke fatigue |
| CN105079407A (en) * | 2014-05-08 | 2015-11-25 | 焦志明 | Traditional herbal medicine composition for preventing cerebral infarction |
| CN105106737A (en) * | 2015-10-10 | 2015-12-02 | 王圣燕 | Traditional Chinese medicine composition used for nerve injury rehabilitation |
| CN105833048A (en) * | 2016-03-16 | 2016-08-10 | 昆明市中医医院 | Pharmaceutical composition, and preparation method, preparation and application thereof |
| CN107952039A (en) * | 2017-12-20 | 2018-04-24 | 苏州工业园区服务外包职业学院 | A kind of medicine prevented and treat apoplexy |
| CN108671191A (en) * | 2018-05-25 | 2018-10-19 | 侯平浩 | A kind of Chinese medicine composition for treating cranial vascular disease |
| DE102018218591A1 (en) * | 2018-10-30 | 2020-04-30 | Guangzhou Baiyun Xinyu Ltd. | Pharmaceutical composition used for a hood for medical and health care |
-
2013
- 2013-06-19 CN CN2013102422751A patent/CN103272188A/en active Pending
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079407A (en) * | 2014-05-08 | 2015-11-25 | 焦志明 | Traditional herbal medicine composition for preventing cerebral infarction |
| CN104027782A (en) * | 2014-06-30 | 2014-09-10 | 吴翠霞 | Foot-bathing traditional Chinese medicinal composition for relieving stroke sequela |
| CN104173927B (en) * | 2014-08-21 | 2018-02-13 | 任有德 | A kind of Chinese medicine composition for treating apoplexy sequela and preparation method thereof |
| CN104173927A (en) * | 2014-08-21 | 2014-12-03 | 任有德 | Traditional Chinese medicine composition for treating cerebral hemorrhage sequelae and preparation method thereof |
| CN104258221A (en) * | 2014-10-17 | 2015-01-07 | 乔世琴 | Traditional Chinese medicine composition for treating blood stasis channel blocking type cerebral embolism and preparation method of composition |
| CN104352969A (en) * | 2014-10-31 | 2015-02-18 | 唐武 | Medicine for treating cerebral hemorrhage sequelae |
| CN104606503A (en) * | 2015-02-12 | 2015-05-13 | 蒋文达 | Traditional Chinese medicine composition for treating stroke sequelae |
| CN104688968A (en) * | 2015-03-04 | 2015-06-10 | 陈红霞 | Traditional Chinese medicine Peiyuanhuanwu decoction for relieving Qi and Yang deficiency type post stroke fatigue |
| CN105106737A (en) * | 2015-10-10 | 2015-12-02 | 王圣燕 | Traditional Chinese medicine composition used for nerve injury rehabilitation |
| CN105833048A (en) * | 2016-03-16 | 2016-08-10 | 昆明市中医医院 | Pharmaceutical composition, and preparation method, preparation and application thereof |
| CN105833048B (en) * | 2016-03-16 | 2019-04-12 | 昆明市中医医院 | A kind of pharmaceutical composition and preparation method thereof, preparation and application |
| CN107952039A (en) * | 2017-12-20 | 2018-04-24 | 苏州工业园区服务外包职业学院 | A kind of medicine prevented and treat apoplexy |
| CN108671191A (en) * | 2018-05-25 | 2018-10-19 | 侯平浩 | A kind of Chinese medicine composition for treating cranial vascular disease |
| DE102018218591A1 (en) * | 2018-10-30 | 2020-04-30 | Guangzhou Baiyun Xinyu Ltd. | Pharmaceutical composition used for a hood for medical and health care |
| DE102018218591B4 (en) | 2018-10-30 | 2020-06-04 | Guangzhou Baiyun Xinyu Ltd. | Pharmaceutical composition used for a hood for medical and health care |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272188A (en) | Agent for curing sequelae of apoplexy | |
| CN101559195A (en) | Epilepsy therapy capsule and preparation method thereof | |
| CN103316174A (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN103385986B (en) | Chinese medicine tincture for treating leucoderma | |
| CN103536877B (en) | Traditional Chinese medicine composition for treating dysmenorrheal | |
| CN103083476B (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN101455712B (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method and use thereof | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN104435678A (en) | Traditional Chinese medicine composition for treating palpitation caused by qi stagnation and blood stasis syndrome | |
| CN103550643A (en) | Traditional Chinese medicine for treating tuberculosis | |
| CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
| CN102008551A (en) | Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN103893601B (en) | A kind of medicament for the treatment of mumps | |
| CN104138572A (en) | Medicine used for treating chloasma | |
| CN103611129A (en) | Traditional Chinese medicine for treating neuropathic headache | |
| CN103638389A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN103479952A (en) | Summer-heat relieving soup | |
| CN1772160A (en) | Chinese medicine prepn for treating immunological sterility | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN103735829A (en) | Traditional Chinese medicine composition for treating spontaneous perspiration | |
| CN103263595A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN103301368A (en) | Medicament for treating hyperactivity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130904 |